XOR risk variants drive diabetic kidney disease
Crossref DOI link: https://doi.org/10.1038/s42255-023-00768-0
Published Online: 2023-04-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Ke
Reiser, Jochen https://orcid.org/0000-0002-0460-662X
Text and Data Mining valid from 2023-04-06
Version of Record valid from 2023-04-06
Article History
First Online: 6 April 2023
Competing interests
: J.R. is co-founder and co-chair of Walden Biosciences, a company targeting kidney diseases.